🔗 Permalink

Inventor profile of:

Michel Demeule

City:

Beaconsfield

Country:

Canada

Published Applications:

Last publication date:

2025-09-25

Top Assignees for applications by Michel Demeule

The entities that hold a legal rights for patent applications filed by inventor Demeule Michel:

Angiochem Inc. 17 Montreal, Canada
ANGIOCHEM INC. 8 Montreal, QC Canada
TRANSFERT PLUS, S.E.C. 3 Montreal, Canada
Angiochem Inc. 2 Montreal, Quebec, Canada
TRANSFERT PLUS, S.E.C. 2 Montreal, QU Canada
TRANSFERT PLUS, S.E.C. 1 MONTRÉAL, QC Canada
Anglachem Inc. 1 Montreal, Canada
Angiochem, Inc. 1 Laval, Canada
TRANSFERT PLUS, SOCIÉTÉ EN COMMANDITE 1 Quebec, Canada
THERATECHNOLOGIES INC. 1 Montreal, Canada
Transfert Plus, S.E.C. 1 Quebec, Canada
TRANSFERT PLUS, S.E.C. 1 MONTREAL, QC Canada
THERATECHNOLOGIES INC. 1 Montreal, QC Canada

Recent patent applications by Demeule Michel

Michel Demeule from Beaconsfield, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-25

US20250296957A1

Chemistry; metallurgy

PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY

#2 | 2024-06-20

US20240199695A1

Chemistry; metallurgy

Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

#3 | 2024-05-16

US20240156971A1

Human necessities

METHODS AND SORTILIN BINDING CONJUGATE COMPOUNDS FOR TARGETING CANCER STEM CELLS

#4 | 2023-02-02

US20230036041A1

Human necessities

SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR TREATING CANCER

#5 | 2022-11-10

US20220356209A1

Chemistry; metallurgy

Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

#6 | 2022-01-06

US20220000971A1

Human necessities

METHODS AND COMPOUNDS FOR TARGETING SORTILIN RECEPTORS AND INHIBITING VASCULOGENIC MIMICRY

#7 | 2020-12-17

US20200392184A1

Chemistry; metallurgy

Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

#8 | 2020-05-21

US20200157151A1

Chemistry; metallurgy

PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES

#9 | 2018-08-09

US20180221497A1

Human necessities

POTENTIATION OF ANTICANCER AGENTS

#10 | 2018-01-18

US20180015180A1

Human necessities

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#11 | 2017-11-16

US20170326233A1

Human necessities

CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERSES THE BLOOD-BRAIN BARRIER, AND A CYTOTOXIN

#12 | 2017-10-05

US20170281787A1

Human necessities

CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERSES THE BLOOD-BRAIN BARRIER, AND A CYTOTOXIN

#13 | 2017-03-23

US20170080100A1

Human necessities

DELIVERY OF ANTIBODIES TO THE CENTRAL NERVOUS SYSTEM

#14 | 2016-12-22

US20160367691A1

Human necessities

TARGETED ENZYME COMPOUNDS AND USES THEREOF

#15 | 2016-09-15

US20160263236A1

Human necessities

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#16 | 2016-09-15

US20160263235A1

Human necessities

PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF

#17 | 2016-07-28

US20160213760A1

Human necessities

APROTININ-DERIVED POLYPEPTIDE-ANTIBODY CONJUGATES

#18 | 2016-04-21

US20160106856A1

Human necessities

CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERSES THE BLOOD-BRAIN BARRIER, AND A CYTOTOXIN

#19 | 2016-01-21

US20160015823A1

Human necessities

Peptide-dendrimer conjugates and uses thereof

#20 | 2015-11-05

US20150314010A1

Human necessities

Potentiation of anticancer agents

#21 | 2015-10-15

US20150290341A1

Human necessities

TARGETED IDURONATE-2-SULFATASE COMPOUNDS

#22 | 2015-06-25

US20150174267A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS

#23 | 2015-06-25

US20150174266A1

Human necessities

APROTININ POLYPEPTIDES FOR TRANSPORTING A COMPOUND ACROSS THE BLOOD-BRAIN BARRIER

#24 | 2015-05-28

US20150147310A1

Chemistry; metallurgy

TARGETED ENZYME COMPOUNDS AND USES THEREOF

#25 | 2015-02-05

US20150038429A1

Human necessities

ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY

#26 | 2015-02-05

US20150037311A1

Human necessities

TARGETED LYSOSOMAL ENZYME COMPOUNDS

#27 | 2014-11-13

US20140335163A1

Chemistry; metallurgy

TARGETED IDURONATE-2-SULFATASE COMPOUNDS

#28 | 2013-10-24

US20130280281A1

Chemistry; metallurgy

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#29 | 2012-11-01

US20120277158A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS

#30 | 2012-08-02

US20120196803A1

Chemistry; metallurgy

FUSION PROTEINS FOR DELIVERY OF GDNF AND BDNF TO THE CENTRAL NERVOUS SYSTEM

#31 | 2012-06-07

US20120141416A1

Human necessities

Multimeric peptide conjugates and uses thereof

#32 | 2012-05-31

US20120135914A1

Human necessities

Etoposide and doxorubicin conjugates for drug delivery

#33 | 2012-05-17

US20120122798A1

Human necessities

Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog

#34 | 2012-01-19

US20120015876A1

Chemistry; metallurgy

Conjugates of GLP-1 agonists and uses thereof

#35 | 2011-11-24

US20110288011A1

Human necessities

PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF

#36 | 2011-11-24

US20110288009A1

Chemistry; metallurgy

LEPTIN AND LEPTIN ANALOG CONJUGATES AND USES THEREOF

#37 | 2011-09-08

US20110218152A1

Chemistry; metallurgy

Compounds for stimulating P-glycoprotein function and uses thereof

#38 | 2011-07-14

US20110171128A1

Human necessities

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

#39 | 2011-05-12

US20110112036A1

Human necessities

Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use

#40 | 2011-02-17

US20110039785A1

Human necessities

POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF

#41 | 2010-11-25

US20100297120A1

Chemistry; metallurgy

Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues

#42 | 2010-10-07

US20100256055A1

Chemistry; metallurgy

Conjugates of neurotensin or neurotensin analogs and uses thereof

#43 | 2009-03-26

US20090082277A1

Human necessities

Potentiation of anticancer agents

#44 | 2009-01-15

US20090016959A1

Chemistry; metallurgy

Delivery of antibodies to the central nervous system

#45 | 2008-12-04

US20080299039A1

Human necessities

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

#46 | 2006-08-24

US20060189515A1

Human necessities

Molecules for transporting a compound across the blood-brain barrier

#47 | 2006-08-17

US20060182684A1

Chemistry; metallurgy

Method for transporting a compound across the blood-brain barrier

InventorID:

496744 ⎘